humax-il8
Showing 1 - 2 of 2
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Nivolumab
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Jul 28, 2022
Solid Tumor Trial run by the (HuMax-IL8)
Completed
- Solid Tumor
- HuMax-IL8
-
Bethesda, MarylandNational Cancer Institute
Feb 1, 2017